ARS Pharmaceuticals Inc. (SPRY) Statistics & Valuation Metrics - Stocknear

ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
10.07
-0.62 (-5.80%)
At close: Sep 05, 2025, 3:59 PM
10.37
2.98%
After-hours: Sep 05, 2025, 07:57 PM EDT

ARS Pharmaceuticals Statistics

Share Statistics

ARS Pharmaceuticals has 97.69M shares outstanding. The number of shares has increased by 1.31% in one year.

97.69M
1.31%
0.1%
77.73%
58.37M
1,223
0.07%

Short Selling Information

The latest short interest is 17.77M, so 17.98% of the outstanding shares have been sold short.

17.77M
17.98%
29.29%
9.54

Valuation Ratios

The PE ratio is 127.87 and the forward PE ratio is -13.6. ARS Pharmaceuticals's PEG ratio is -1.12.

127.87
-13.6
11.47
5.2
3.98
78.76
-1.12
Financial Ratio History

Enterprise Valuation

ARS Pharmaceuticals has an Enterprise Value (EV) of 971.91M.

10.9
-338.05
71.74
74.85

Financial Position

The company has a current ratio of 14.26, with a Debt / Equity ratio of 0.

14.26
14.04
0
-0.01
n/a
0

Financial Efficiency

Return on Equity is 3.11% and Return on Invested Capital is -0.91%.

3.11%
2.28%
-0.91%
$575.15K
$51.6K
155
0.25
0.19

Taxes

288K
3.48%

Stock Price Statistics

The stock price has increased by -9.02% in the last 52 weeks. The beta is 0.92, so ARS Pharmaceuticals's price volatility has been higher than the market average.

0.92
-9.02%
16.21
13.83
22.01
1,793,364

Income Statement

In the last 12 months, ARS Pharmaceuticals had revenue of 89.15M and earned 8M in profits. Earnings per share was 0.08.

89.15M
88.17M
-3.08M
8M
-2.88M
-3.08M
0.08
Full Income Statement

Balance Sheet

The company has 50.82M in cash and 42K in debt, giving a net cash position of 50.77M.

50.82M
42K
50.77M
-123.31M
313.47M
235.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.55M and capital expenditures -563K, giving a free cash flow of 12.98M.

13.55M
-563K
12.98M
0.13
Full Cash Flow Statement

Margins

Gross margin is 98.9%, with operating and profit margins of -3.46% and 8.97%.

98.9%
-3.46%
9.29%
8.97%
-3.22%
-3.46%
14.57%

Dividends & Yields

SPRY does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
0.78%
1.27%
Dividend Details

Analyst Forecast

The average price target for SPRY is $29, which is 171.3% higher than the current price. The consensus rating is "Buy".

$29
171.3%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
2.22
-79.23%

Scores

7.34
1